Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo D'Alessandro

Showing results (571-580 of 618) with videos related to

Pageof 62
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2021
Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansionIsak W Tengesdal, Dinoop R Menon, Douglas G Osborne, et al.
Leukemia|June 13, 2021
Metabolic alterations mediated by STAT3 promotes drug persistence in CMLSweta B Patel, Travis Nemkov, Davide Stefanoni, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2018
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammationCarlo Marchetti, Benjamin Swartzwelter, Fabia Gamboni, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
The COVIDome Explorer Researcher PortalKelly D Sullivan, Matthew D Galbraith, Kohl T Kinning, et al.
Haematologica|April 6, 2023
Simultaneous inhibition of Sirtuin 3 and cholesterol homeostasis targets acute myeloid leukemia stem cells by perturbing fatty acid β-oxidation and inducing lipotoxicityCristiana O'Brien, Tianyi Ling, Jacob M Berman, et al.
Research Square|February 26, 2024
Metformin reduces the clonal fitness of <i>Dnmt3a</i> <sup>R878H</sup> hematopoietic stem and progenitor cells by reversing their aberrant metabolic and epigenetic stateMohsen Hosseini, Veronique Voisin, Ali Chegini, et al.
Cancer Research|April 29, 2020
Identification of a Small-Molecule Inhibitor That Disrupts the SIX1/EYA2 Complex, EMT, and MetastasisHengbo Zhou, Melanie A Blevins, Jessica Y Hsu, et al.
NPJ Breast Cancer|May 20, 2023
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancerAnthony D Elias, Nicole S Spoelstra, Alyse W Staley, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2022
Specialized interferon action in COVID-19Matthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Hemasphere|April 20, 2026
Improved red blood cell storage quality of blood from donors carrying the hypermorphic PIMT I120 variantShaun Bevers, Aaron V Issaian, Ariel Hay, et al.
Pageof 62

Showing results (571-580 of 618) with videos related to

Sort By:
Pageof 62
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2021
Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansionIsak W Tengesdal, Dinoop R Menon, Douglas G Osborne, et al.
Leukemia|June 13, 2021
Metabolic alterations mediated by STAT3 promotes drug persistence in CMLSweta B Patel, Travis Nemkov, Davide Stefanoni, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2018
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammationCarlo Marchetti, Benjamin Swartzwelter, Fabia Gamboni, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
The COVIDome Explorer Researcher PortalKelly D Sullivan, Matthew D Galbraith, Kohl T Kinning, et al.
Haematologica|April 6, 2023
Simultaneous inhibition of Sirtuin 3 and cholesterol homeostasis targets acute myeloid leukemia stem cells by perturbing fatty acid β-oxidation and inducing lipotoxicityCristiana O'Brien, Tianyi Ling, Jacob M Berman, et al.
Research Square|February 26, 2024
Metformin reduces the clonal fitness of <i>Dnmt3a</i> <sup>R878H</sup> hematopoietic stem and progenitor cells by reversing their aberrant metabolic and epigenetic stateMohsen Hosseini, Veronique Voisin, Ali Chegini, et al.
Cancer Research|April 29, 2020
Identification of a Small-Molecule Inhibitor That Disrupts the SIX1/EYA2 Complex, EMT, and MetastasisHengbo Zhou, Melanie A Blevins, Jessica Y Hsu, et al.
NPJ Breast Cancer|May 20, 2023
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancerAnthony D Elias, Nicole S Spoelstra, Alyse W Staley, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2022
Specialized interferon action in COVID-19Matthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Hemasphere|April 20, 2026
Improved red blood cell storage quality of blood from donors carrying the hypermorphic PIMT I120 variantShaun Bevers, Aaron V Issaian, Ariel Hay, et al.
Pageof 62